4 Einträge gefunden

1. Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia

   1. Al Hamed, Rama
   2. Labopin, Myriam
   3. Daguindau, Etienne
   4. Niittyvuopio, Riitta
   5. Huynh, Anne
   6. Socié, Gerard
   7. Srour, Micha

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)

   1. Saraceni, Francesco
   2. Labopin, Myriam
   3. Forcade, Edouard
   4. Kröger, Nicolaus
   5. Socié, Gerard
   6. Niittyvuopio, Riitta
   7. Cornelissen, Jan J

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation

   1. Nagler, Arnon
   2. Labopin, Myriam
   3. Canaani, Jonathan
   4. Niittyvuopio, Riitta
   5. Socié, Gerard
   6. Kröger, Nicolaus
   7. Itäla-Remes, Maija

   2020 - Forschungsinformationssystem des UKE - frei zugänglich
4. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

   1. Pavlů, Jiří
   2. Labopin, Myriam
   3. Niittyvuopio, Riitta
   4. Socié, Gerard
   5. Yakoub-Agha, Ibrahim
   6. Wu, Depei
   7. Remenyi, Peter

   2019 - Forschungsinformationssystem des UKE - frei zugänglich